Patents by Inventor Thomas M. Stein

Thomas M. Stein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108220
    Abstract: A method and apparatus for monitoring collection of subject condition data is provided. The method includes receiving a value of a parameter of subject condition data and a value of a sample time, for each of a plurality of sample times. The method also includes storing the subject condition data in a data structure including a first field for holding data indicating a current sample time and a second field for holding data indicating the value of the parameter. The method also includes determining a time gap defined by a duration between the current sample time and a most recent sample time and determining whether the time gap exceeds a time gap threshold and causing an apparatus to perform remedial action. A method for presenting the subject condition data on a display is also provided.
    Type: Application
    Filed: April 4, 2023
    Publication date: April 4, 2024
    Inventors: Fu-Ming Hu, Lynn G. Stansbury, Colin F. Mackenzie, Thomas M. Scalea, Deborah M. Stein, Shiming Yang
  • Patent number: 8747889
    Abstract: A transdermal analgesic system having reduced potential for abuse, wherein the system provides for the controlled release of the antagonist at a rate sufficient to provide an abuse limiting release rate ratio of the antagonist to the analgesic when the dosage form is subject to abuse is disclosed.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: June 10, 2014
    Assignee: Durect Corporation
    Inventors: Robert M. Gale, Thomas M. Stein, Jay Audett, Jane Stepic, Joseph B. Phipps, Michael J. N. Cormier
  • Patent number: 8440220
    Abstract: A transdermal analgesic system having reduced potential for abuse, wherein the system provides for the controlled release of the antagonist at a rate sufficient to provide an abuse limiting release rate ratio of the antagonist to the analgesic when the dosage form is subject to abuse is disclosed.
    Type: Grant
    Filed: April 22, 2003
    Date of Patent: May 14, 2013
    Assignee: Durect Corporation
    Inventors: Robert M. Gale, Thomas M. Stein, Jay Audett, Jane Stepic, Joseph B. Phipps, Michel J. N. Cormier
  • Publication number: 20040013716
    Abstract: A transdermal analgesic system having reduced potential for abuse, wherein the system provides for the controlled release of the antagonist at a rate sufficient to provide an abuse limiting release rate ratio of the antagonist to the analgesic when the dosage form is subject to abuse is disclosed.
    Type: Application
    Filed: April 22, 2003
    Publication date: January 22, 2004
    Inventors: Robert M. Gale, Thomas M. Stein, Jay Audett, Jane Stepic, Joseph B. Phipps, Michel J.N. Cormier
  • Patent number: 6365341
    Abstract: The present invention discloses the use of quaternary compounds as stabilizing agents for highly-sensitive fluorescent nucleic acid stains in aqueous solvents, their use in gels to give increased usable shelf life, and in compositions of solvents, providing ready-to-use stain solutions.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: April 2, 2002
    Assignee: BioWhittaker Molecular Applications, Inc.
    Inventors: Minjie Wu, Hugh W. White, Noriko Kusukawa, Thomas M. Stein